Search | TVST | ARVO Journals

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Development of an in vivo cell culture model for the treatment of corneal epithelial lesions

Natalia Vázquez; Diana Albino; Sergio Alonso-Alonso; Manuel Chacon; Mairobi Persinal-Medina; Laura Maria Martinez-Lopez; Sara Llames; Marta Pevida; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2007.

Cornea & External Disease November 2023

Biological and Adhesive Properties of an Autologous Protein-Based Fibrin Sealant for Ophthalmological Applications

PDF

Eduardo Anitua; Francisco Muruzabal; Roberto Prado; Ander Pino; Roberto Tierno; Mairobi Persinal-Medina; Mohammad H. Alkhraisat; Jesús Merayo-Lloves
TAGS: adhesives, fibrin tissue adhesive, proteins, growth factor, adhesions
Trans. Vis. Sci. Tech.. 2023; 12(11):32. https://doi.org/10.1167/tvst.12.11.32

ARVO Annual Meeting Abstract June 2023

Antifibrotic activity of Siempreviva sap for potential pterygium treatment

Katiana Flores Nucamendi; Mairobi Persinal-Medina; David Eguenio Rodriguez; Alfredo Del Castillo; Karla Carrasco; Daniel Dares; Alberto Castilo; Judith Zavala; Jorge E Valdez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):206.

ARVO Annual Meeting Abstract June 2023

Cultured oral mucosal and Adipocytic msc in an alkaline chemical burn of the cornea in an experimental model

Alvaro Meana; Mairobi Persinal-Medina; Natalia Vázquez; Manuel Chacon; Sergio Alonso-Alonso; Sara Llames; Marta Pevida; Jesus Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3117.

ARVO Annual Meeting Abstract June 2023

Electrochemical impedance spectroscopy as an alternative to the Draize eye irritation test

Manuel Chacon; Natalia Vázquez; Sergio Alonso-Alonso; Mairobi Persinal-Medina; Ignacio Alcalde; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5192.

ARVO Annual Meeting Abstract June 2023

Feasibility of a Corneal Endothelial Cell Therapy using two in vitro corneal models.

Sergio Alonso-Alonso; Natalia Vázquez; Manuel Chacon; Alvaro Meana; Jesus Merayo-Lloves; Mairobi Persinal-Medina

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):625.

ARVO Annual Meeting Abstract June 2022

Use of plasma rich in growth factors in a macular hole in vivo model

Susana del Olmo Aguado; Jaime Larrea González; Nagore de Pablo; Mairobi Persinal Medina; Enol Artime; Sergio Alonso-Alonso; Jesus Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3749 – F0170.

ARVO Annual Meeting Abstract June 2022

Comparison of mRNA expression in primary cultures of human anterior lens epithelium and human corneal endothelium.

Sergio Alonso-Alonso; Natalia Vázquez; Manuel Chacon; Mairobi Persinal-Medina; Noemí Caballero-sánchez; Laszlo Nagy; Luis Fernández-Vega-Cueto-Felgueroso; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2734 – A0223.

ARVO Annual Meeting Abstract June 2022

Performance assessment of QobuR-RhCE – a cruelty-free in vitro cornea model

Manuel Chacon; Natalia Vázquez; Mairobi Persinal-Medina; Sergio Alonso-Alonso; Ignacio Alcalde; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):686 – F0140.

ARVO Annual Meeting Abstract June 2021

Development of a new xeno-free human corneal endothelial cells culture system based on Platelet Rich in Growth Factors.

Sergio Alonso-Alonso; Natalia Vázquez; Carlota Suarez-Barrio; Susana del Olmo Aguado; Manuel Chacon; Eva Garcia-Perez; Mairobi Persinal-Medina; José F. Alfonso; Belén Alfonso; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):828.

ARVO Annual Meeting Abstract June 2021

Evaluation of ocular irritancy based on cell membrane capacitance on a cruelty-free in vitro corneal model

Manuel Chacon; Natalia Vázquez; Mairobi Persinal-Medina; Sergio Alonso-Alonso; Ignacio Alcalde; Manuel Sánchez; Luis Fernandez-Vega-Cueto; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):734.

ARVO Annual Meeting Abstract June 2021

Oral mucosa culture system for ocular surface treatment avoiding the use of xenogeneic components

Alvaro Meana; Mairobi Persinal-Medina; Natalia Vázquez; Manuel Chacon; Sergio Alonso-Alonso; Carlos Fernández-Vega-González; Jose I Blazquez; Sara Llames; Jesus Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):758.

ARVO Annual Meeting Abstract June 2020

Xeno-free and minimally invasive approach for ocular therapies based on mesenchymal stem cells

Jesus Merayo-Lloves; Mairobi Persinal-Medina; Natalia Vazquez; Manuel Chacon; Sergio Alonso-Alonso; Luis Fernandez-Vega-Cueto; Begoña Baamonde; Jose I. Blazquez; Carlos Lisa; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1199.

ARVO Annual Meeting Abstract June 2020

Cruelty-free corneal damage assay based on automatic high-throughput cell capacitance

Manuel Chacon; Maria Begoña Gonzalez-Garcia; Daniel Izquierdo-Bote; Manuel Sanchez; Natalia Vazquez; Silvia Berisa; Mairobi Persinal-Medina; Sergio Alonso-Alonso; Jesus Merayo-Lloves; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2973.

ARVO Annual Meeting Abstract June 2020

Corneas discarded by low endothelial count: a source of human corneal endothelial cells (hCECs).

Alvaro Meana; Natalia Vazquez; Sergio Alonso-Alonso; Carlota Suarez-Barrio; Susana del Olmo Aguado; Manuel Chacon; Eva Garcia-Perez; Mairobi Persinal-Medina; Miguel Naveiras; Jose F. Alfonso; Jesus Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3597.

ARVO Annual Meeting Abstract July 2019

Low scale production of advanced therapy medicinal products for limbal stem cell deficiency.

Alvaro Meana; Silvia Berisa; Manuel Chacon; Natalia Vazquez; MAIROBI PERSINAL MEDINA; Begoña Baamonde; Jose Alfonso; Luis Fernandez-Vega; Jesus Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4104.

ARVO Annual Meeting Abstract July 2019

Plasma Rich in Growth Factors membrane in the treatment of Limbal Stem Cell Deficiency.

Jesus Merayo-Lloves; Ronald Sanchez-Avila; Manuel Chacon; Natalia Vazquez; Silvia Berisa; MAIROBI PERSINAL MEDINA; Carlos Lisa; Miguel Naveiras; Alvaro Meana

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6314.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development of an in vivo cell culture model for the treatment of corneal epithelial lesions

Biological and Adhesive Properties of an Autologous Protein-Based Fibrin Sealant for Ophthalmological Applications

Antifibrotic activity of Siempreviva sap for potential pterygium treatment

Cultured oral mucosal and Adipocytic msc in an alkaline chemical burn of the cornea in an experimental model

Electrochemical impedance spectroscopy as an alternative to the Draize eye irritation test

Feasibility of a Corneal Endothelial Cell Therapy using two in vitro corneal models.

Use of plasma rich in growth factors in a macular hole in vivo model

Comparison of mRNA expression in primary cultures of human anterior lens epithelium and human corneal endothelium.

Performance assessment of QobuR-RhCE – a cruelty-free in vitro cornea model

Development of a new xeno-free human corneal endothelial cells culture system based on Platelet Rich in Growth Factors.

Evaluation of ocular irritancy based on cell membrane capacitance on a cruelty-free in vitro corneal model

Oral mucosa culture system for ocular surface treatment avoiding the use of xenogeneic components

Xeno-free and minimally invasive approach for ocular therapies based on mesenchymal stem cells

Cruelty-free corneal damage assay based on automatic high-throughput cell capacitance

Corneas discarded by low endothelial count: a source of human corneal endothelial cells (hCECs).

Low scale production of advanced therapy medicinal products for limbal stem cell deficiency.

Plasma Rich in Growth Factors membrane in the treatment of Limbal Stem Cell Deficiency.

To View More...

You must be signed into an individual account to use this feature.